BP control in certain acute hypotensive states (eg, pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesth, MI, septicemia, blood transfusion, & drug reactions). Adjunctive treatment of cardiac arrest & profound hypotension.
Administer as a single dose of 8 mg in 1,000 mL of dextrose 5% or normal saline 0.9% inj in a ratio of 2-3 mL/min as IV drip. Maintenance dose: 0.5-1 mL/min.
Allergenic cross-sensitivity w/ vasopressors. Hypotension from hypovolemia. Mesenteric or peripheral vascular thrombosis. Concomitant use w/ cyclopropane or halothane anesth.
Patients receiving MAOIs or triptyline/imipramine type antidepressants. Assure adequate circulatory vol. Avoid HTN; extravasation; infusion into leg veins in elderly patients & those suffering from occlusive disorders (eg, atherosclerosis, arteriosclerosis, diabetic endarteritis, Buerger disease); catheter tie-in technique. Closely monitor BP, IV site & adjust infusion rate. Patients w/ profound hypoxia or hypercarbia. Ensure proper needle or catheter placement prior to, & during infusion. Administer phentolamine when extravasation occurs. Patients w/ asthma or sulfite allergy. Gangrene in a lower extremity. Pregnancy & lactation. Elderly ≥65 yr.
C01CA03 - norepinephrine ; Belongs to the class of adrenergic and dopaminergic cardiac stimulants excluding glycosides. Used in the treatment of hypotension.
Sign Out
